(Sharecast News) - Private healthcare group Mediclinic said it expected expects full-year revenues to grow by around 6.5% as its strong first half performance continued.
Mediclinic added that its earnings before interest, tax, depreciation and amortisation (EBITDA) margin remained unchanged.
As a result of higher staffing levels, together with an expected lower margin contribution from the Intercare business and the ramp-up of its new Stellenbosch facility, Mediclinic anticipated a full-year EBITDA margin of around 20%.
As of 0840 GMT, Mediclinic shares were up 1.04% to 388.90p.
7 Feb 2020 07:40
Mediclinic gets green light for South Africa purchase
(Sharecast News) - Healthcare services group Mediclinic International said South Africa's competition appeal court had cleared its purchase of a controlling stake in Matlosana Medical Health Services.
Read more